Analyses of large somatic mutation datasets, using advanced computational algorithms, have revealed at least 30 independent mutational signatures in tumor samples. These studies have been instrumental in identification and quantification of responsible endogenous and exogenous molecular processes against cancer. The quantitative approach used to deconvolute mutational signatures is becoming an integral part of cancer research. Therefore, development of a stand-alone tool with a user-friendly graphical interface for analysis of cancer mutational signatures is necessary.
INTRODUCTION
Aberrant somatic changes in DNA resulting from endogenous sources (e.g. APOBEC-induced mutagenesis and DNA repair defects) and exogenous factors (e.g. tobacco smoking and UV radiation) are the hallmark of cancer. These alternations in DNA may have different forms, ranging from gross chromosomal rearrangements to single base substitutions [1] . The whole genome sequencing of tumor cells has shown that the number of mutations varies from less than one hundred per genome to hundreds of thousands depending on the cancer type and patient. Moreover, the type of mutation and sequence context of many cancer mutations are not random. For instance, C-to-T mutation within the CG (a.k.a. CpG) dinucleotide is a prevalent mutation in cancer and as its abundance is proportional to the age of patient it is referred to as an "aging" signature [2] . Many cancers also have a large number of C-to-T and C-to-G mutations within TCA and TCT trinucleotides [3] . These mutations are attributed to the aberrant changes in the level and activity of APOBEC enzymes. The discovery of mutational signatures was a breakthrough in the field of cancer research. Therefore, the mathematical framework developed by Alexandrov et al. [4] is now routinely used to identify novel mutational signatures and to study the processes involved in different cancers and in different patients. To help the progress of this field, we have developed a computational tool, CANCERSIGN, which enables the users to easily apply a matrix factorization analysis to cancer mutation datasets and receive a complete set of mutational signatures. Compared to the previously developed packages in R [6] [7] [8] , CANCERSIGN is unique in that it is a stand-alone package (i.e. it does not require additional software programming). Therefore, to use this tool, no programming skills are required. Additionally, it enables the users to perform de novo mutational signature analyses.
Application of CANSERSIGN is not limited to extracting mutational signatures based on nucleotides
immediately flanking the mutated site (i.e. tri-nucleotide motifs). It allows the users to extend the analysis to two bases on each side of the mutated base (i.e. penta-nucleotides motifs). According to a recent study [9] , taking larger sequence contexts into consideration provides a greater power to explain variability in genomic substitution probabilities. In addition, CANCERSIGN allows the user to select trinucleotides of interest, and determine their penta-nucleotide mutational signatures.
Furthermore, it has a built-in clustering option to study the groupings of cancer samples based on the raw mutation counts and/or composition of mutational signatures. In this manuscript, we introduce CANCERSIGN and show the new mutational signatures obtained from a de novo analysis of whole genome ICGC dataset. This analysis was performed for each cancer type separately and resulted in 78 mutational signatures. Each of the obtained signatures were shown to be highly similar to at least one of the 30 signatures discovered previously [2] , except 5 signatures that can be considered as novel.
DATA and METHODS
To develop CANCERSIGN and demonstrate its application, we used all the whole genome mutation datasets available at the International Cancer Genome Consortium (ICGC) data portal. A summary of the datasets used is shown in Supplementary table 1.
A schematic of CANCERSIGN features is given in Supplementary figure 1. This tool deciphers mutational signatures in somatic mutation datasets using a previously reported non-negative matrix factorization (NMF) model [4] . It only requires a dataset of mutations in a simple format described in the tool manual (https://github.com/masroor-bayati/cancer_analysis_tool and https://github.com/icticbioinformatics/CANCERSIGN).
CANCERSIGN then performs the requested analyses and outputs mutational signatures (3-mer and/or 5-mer formats) and clustering figures. The numerical outputs of the analyses are saved in a folder named "output" (refer to the CANCERSIGN manual). This data can be used to gain further insight into mutational processes in cancer. For example, the exposure matrix obtained from the NMF analysis, can be used to determine the prevalence of each mutational signature in each sample.
Estimation of mutational signatures
Each mutational signature is defined by a total of 96 types of mutations within tri-nucleotide motifs [4] .
Assuming that Here, each column of P is interpreted as one mutational signature and each row of E represents the exposures of each mutational signature in the corresponding sample genome (i.e. the prevalence of each mutational signature in that sample). The process of estimating independent mutational signatures from a mutational catalogue matrix is done using a nonnegative matrix factorization (NMF) method. Note that the elements of the input catalogue matrix are nonnegative because they represent the number of mutations.
The algorithm used in this framework consists of several iterative steps. The overall procedure is as follows. Each iteration starts with sampling from matrix M and creating a new bootstrapped matrix ‫ܯ‬ .
To do this, each column of M (mutation counts of one input cancer genome) is considered a discrete probability distribution and is resampled to create the corresponding column of ‫ܯ‬ . Next, the bootstrapped matrix ‫ܯ‬ is factorized into matrices P and E by applying the NMF algorithm. These steps will be repeated for a certain number of iterations (typically 600 iterations are enough to obtain a stable result). The resulting matrices obtained after each iteration are stored and grouped into two sets: P matrices and E matrices named CANCERSIGN is designed to carry out each iteration of the aforementioned algorithm, which consists of one bootstrap and a complete NMF decomposition, independent and in parallel with other iterations.
This enables the user to distribute the whole task across CPU cores and speed up the procedure of extracting mutational signatures. This tool also allows the user to specify the convergence criteria, the number of NMF iterations, the number of bootstrapping iterations and the number of CPU cores for parallelization.
Penta-nucleotide mutational signatures
In addition to extracting mutational signatures based on the immediately flanking nucleotides around the mutated site (tri-nucleotides), CANCERSIGN enables the user to further investigate the underlying mutational process, by expanding the mutational context to two bases upstream and downstream of the mutated base (penta-nucleotides). For this purpose, the user can choose an arbitrary set of mutations in tri-nucleotide motifs (up to 10 combinations). For each of these selected motifs, our tool quantifies the number of mutations in the corresponding 16 penta-nucleotide motifs (e.g. when the motif C [G>T] A is selected, 16 penta-nucleotide motifs of the form NC [G>T] AN are considered where N is each of four nucleotides). The mutation counts of penta-nucleotides in all samples are then used as the input to the NMF analysis, which produces a set of penta-nucleotide (or 5-mer) mutational signatures.
Clustering of samples
One important application of CANCERSIGN is clustering of tumors based on mutations within selected motifs (Matrix M in eq. 1) or based on the prevalence of mutational signatures (Exposure Matrix E in eq. 1). This feature allows the user to investigate between sample heterogeneity and to identify potential outlier samples. Additionally, this information can be used to investigate correlation with clinical data including treatment history and survival outcomes.
The clustering of samples is done using the k-means algorithm with Euclidian distance measure and random initial seeds via k-means++ method [11] . The algorithm repeats the clustering procedure several times to find a stable solution. The optimum value for the number of clusters is heuristically determined by measuring the within cluster sum of squares (WSS) against the number of clusters and finding the point after which this measure does not decrease dramatically (i.e. approximately stabilizes). To visualize the result of clustering, CANCERSIGN produces two types of plots. The first plot visualizes the clustering centroids, which are obtained by averaging over features of the members of each cluster. The second plot visualizes a projection of the samples in a 2D plane to show how samples within a cluster are similar to each other and different from samples in other clusters. To do this, the tool performs a principal component analysis (PCA) and generates a PC1-PC2 plot. The user can find the sample IDs associated with each cluster by using tabular files produced by the tool (see
CANCERSIGN manual).
A snapshot of CANCERSIGN is provided in Figure 1 .
We have applied our tool to the mutational data of various cancers (18 types-Supplementary table 1) and presented the results. The ICGC somatic mutations dataset (last updated June 2017) is used for this analysis. General information and statistics about the data can be found in Supplementary table1. Details about our analyses, including the tool parameters, are provided in supplementary information.
RESULTS AND DISCUSSION
The results of separate analyses of whole genome mutation data from each of 18 tumor types (Figures 2A-2R ). The majority of these signatures were highly similar (Cosine Similarity > 50) to one or more of the previously reported 30 signatures [2] . But five of these signatures had a Cosine similarity of <50, suggesting that they are possibly novel signatures that have not been identified previously (Figure 3 ). For example, Figure 2A indicates 10 mutational signatures deciphered from the mutational data of breast cancer samples by using CANCERSIGN. For each of these 10 signatures there is at least one previously reported signature which can be considered as a close match (Figure 3) . Figure 2B shows the mutational signatures that Figure 6 . Based on the estimated proportion of the 10 signatures of breast cancer, CANCERSIGN classified the samples into three distinct groups (Figure 6 ). The second option is clustering based on the proportions of 3-mer motifs. The selected motifs were T(C- Figure 7 .
>G)A, T(C->G)T, T(C->T)A and T(C->T)T. The result of this clustering is shown in
Another feature of CANCERSIGN is to decipher mutational signatures based on mutations within specific 5-mer motifs. To demonstrate this feature, we selected two 3-mer motifs (TCA and TCT) and two mutation types (C>T and C>G) as an input (i.e.
T(C>G)A, T(C>G)T, T(C>T)A and T(C>T)T).
These mutations are attributed to APOBEC enzymes and are the most abundant mutations in many 
Comparison with other tools
We have compared our tool with its well-known counterparts which have been developed for similar purposes: SomaticSignatures [6], SigneR [7] and deconstructSigs [8] . The deconstructSigs package is different from other tools as it is designed to determine the optimal linear combination of pre-defined mutational signatures that most accurately reconstructs the mutational profile of a single tumor sample [8] , whereas others are designed to extract de novo mutational signatures from a cohort. Table 1 compares the tools based on a set of features. Note that this comparison only considers relevant features of these tools rather than all capabilities. Please refer to the corresponding papers for more information [6] [7] [8] .
The tools were applied to a simulated dataset of mutations. We constructed the simulated dataset as follows: 6 signatures were selected from the list of mutational signatures presented at the COSMIC database [5] (signatures 1, 2, 3, 17, 21 and 29) as the underlying mutational processes, producing our simulated mutational catalogue. The mutational load (total mutations) for each sample was determined by taking a random number from a Rayleigh distribution with parameter ߪ ൌ 8 0 0 0 (this distribution was used since we observed that the histogram of mutational loads for samples of a cancer is often unimodal and positively skewed, and the average of mutational loads across all samples and all cancer types is near 10'000 which is approximately equal to the mean of a Rayleigh distribution with scale parameter of 8000). In the next step, the vector of mutations for each sample was generated by a linear combination of the 6 signatures where the 6 coefficients were determined randomly (for each set of coefficients, we selected 6 random numbers between 0 to 1, then normalized them such that they sum up to 1, and finally multiply them with the amount of mutational load of the sample). The aforementioned algorithm were used to generate 400 samples to form the simulated mutational catalogue.
We tried to apply CANCERSIGN, SomaticSignatures and SigneR to the simulated dataset in an equal condition. However, due to its Bayesian framework, SigneR is not scalable to large mutational catalogues containing several hundreds of samples. Consequently, it is not feasible to test SigneR on the simulation dataset, and instead performed the comparison between CANCERSIGN and
SomaticSignatures.
The parameters of the analysis were set as follows. The range of values of N (number of signatures to decipher) was set from 2 to 12. The maximum number of bootstraps for each N was set to 100 for CANCERSIGN, and the number of replicates (nReplicates) for SomaticSignatures was set to 20. With these settings, the tools consumed approximately the same amount of time (~45 minutes) to decipher mutational signatures from our simulated dataset (using a typical computer with four 1.7 GHz CPU cores and 8GB memory). According to Figure 9 , both tools have correctly found N = 6 as the optimal number of underlying mutational signatures (the knee point in the diagram of summary statistics of This diagram abstracts the functional features of our tool. The user can either choose to extract mutational signatures in the conventional format which are the spectrums over 96 mutation types (3-mer motifs) or extract 5-mer mutational signatures. The box indicating "NMF algorithm" consists of several steps. Its main steps are bootstrapping from mutational catalogue matrix, NMF iteration and clustering the results obtained from the bootstrapped data. In the clustering part, the user can choose different sets of features to cluster the samples. These feature sets are based on either mutational motifs or mutational signatures. In the former case, counts or proportions of 3-mer or 5-mer mutational motifs can be selected, and in the latter case, contributions of 3-mer or 5-mer mutational signatures can be chosen for clustering features. Finally, in the simulation part, there are two options to simulate the mutational catalogues and in either case, it produces simulated signatures to examine the statistical significance of deciphered signatures from the input data. Here, each cell indicates percentage of similarity between signatures identified by our tool and previously reported signatures. Those signatures with less than 50% similarity with previously reported signatures have been highlighted. T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T 
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